SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-13-002262
Filing Date
2013-06-19
Accepted
2013-06-19 11:16:48
Documents
2
Period of Report
2013-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_061313.htm 8-K 19785
2 COMPENSATION COMMITTEE CHARTER ADOPTED ON JUNE 13, 2013 ex10-34.htm EX-10.34 26901
  Complete submission text file 0001387131-13-002262.txt   48078
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 13921130
SIC: 2834 Pharmaceutical Preparations